{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:06:41Z","timestamp":1778213201048,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["20677"],"award-info":[{"award-number":["20677"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Our overall aim was to develop a smartphone app to collect photographic images of Raynaud\u2019s phenomenon (RP) attacks alongside patient reported outcome measures (PROMs). Specific objectives included assessing the feasibility of patients documenting RP attacks using mobile phones, developing image analysis methods to document colour change, and comparing photographic parameters with \u2018non-imaging\u2019 app and paper diary parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In study 1, 36 patients with systemic sclerosis (SSc)-related RP photographed RP attacks over 15\u2009days as well as completing an RP paper diary. In study 2, 40 patients with either SSc-related or primary RP used a smartphone app to collect, over 15\u2009days, photographic images and data including frequency and severity of attacks. In both studies, mean colour change during each attack (indicating severity) was quantified by the Bhattacharyya distance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In study 1, 24\/36 (67%) patients completed the study of whom 22 photographed at least one RP attack (median number of attacks 12.5, range 1\u201353); 18\/24 (75%) patients preferred phone to paper diary documentation. \u2018Photographic\u2019 and \u2018paper diary\u2019 frequency (but not severity) of attacks correlated strongly, with a correlation coefficient of 0.71 (95% CI: 0.41, 0.87); P\u2009=\u20090.002. In study 2, 36\/40 (90%) completed the study, providing 1747 usable images from 456 RP attacks. ANOVA demonstrated that RP colour change was significantly different with different values of RP attack severity (P\u00a0&amp;lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Collecting photographs of RP attacks and PROMS via a smartphone app was feasible and preferred by patients to data collection via paper diary, providing proof-of-concept for validation studies of app-based outcome measures for RP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf141","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T18:56:36Z","timestamp":1741805796000},"page":"4236-4244","source":"Crossref","is-referenced-by-count":7,"title":["Using a smartphone app to monitor Raynaud\u2019s attacks and quantify skin colour changes\u2014towards objective outcome measures for Raynaud\u2019s"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-2721","authenticated-orcid":false,"given":"Graham","family":"Dinsdale","sequence":"first","affiliation":[{"name":"Rheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust , Salford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9244-2882","authenticated-orcid":false,"given":"Andrea","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Manning","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust , Salford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Photon Science Institute, The University of Manchester , Manchester,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-7926","authenticated-orcid":false,"given":"Ariane L","family":"Herrick","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust , Salford,","place":["UK"]},{"name":"Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris J","family":"Taylor","sequence":"additional","affiliation":[{"name":"Centre for Imaging Sciences, Institute of Population Health, The University of Manchester , Manchester,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025070205021885900_keaf141-B1","doi-asserted-by":"crossref","first-page":"101474","DOI":"10.1016\/j.berh.2019.101474","article-title":"Raynaud's phenomenon","volume":"34","author":"Herrick","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025070205021885900_keaf141-B2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-031-52581-0_3","volume-title":"Raynaud's phenomenon: from pathogenesis to management","author":"Kumar","year":"2024","edition":"2nd edn"},{"key":"2025070205021885900_keaf141-B3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025070205021885900_keaf141-B4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology"},{"key":"2025070205021885900_keaf141-B5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","article-title":"Prediction and impact of attacks of Raynaud\u2019s phenomenon, as judged by patient perception","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology"},{"key":"2025070205021885900_keaf141-B6","first-page":"CD002069","article-title":"Calcium channel blockers for primary Raynaud\u2019s phenomenon","volume":"2","author":"Ennis","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025070205021885900_keaf141-B7","first-page":"CD000467","article-title":"Calcium channel blockers for primary and secondary Raynaud's phenomenon","volume":"2017","author":"Rirash F, Tingey PC, Harding SE","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025070205021885900_keaf141-B8","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2665-9913(19)30079-7","article-title":"Comparative efficacy and safety of treatments for secondary Raynaud\u2019s phenomenon: a systematic review and network meta-analysis of randomised trials","volume":"1","author":"Khouri","year":"2019","journal-title":"Lancet Rheumatolol"},{"key":"2025070205021885900_keaf141-B9","first-page":"CD006687","article-title":"Vasodilators for primary Raynaud's phenomenon","volume":"5","author":"Su","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025070205021885900_keaf141-B10","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2025070205021885900_keaf141-B11","first-page":"1630","article-title":"Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6","volume":"30","author":"Merkel","year":"2003","journal-title":"J Rheumatol"},{"key":"2025070205021885900_keaf141-B12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-1526-2_17","volume-title":"Raynaud's phenomenon: a guide to pathogenesis and treatment","author":"Khanna","year":"2015"},{"key":"2025070205021885900_keaf141-B13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/acr.21858","article-title":"Evaluation of test characteristics for outcome measures used in Raynaud\u2019s phenomenon clinical trials","volume":"65","author":"Gladue","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2025070205021885900_keaf141-B14","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.40242","article-title":"Efficacy and safety of selexipag in adults with Raynaud\u2019s phenomenon secondary to systemic sclerosis. A randomized, placebo-controlled, Phase II Study","volume":"69","author":"Denton","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025070205021885900_keaf141-B15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification criteria for systemic sclerosis","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025070205021885900_keaf141-B16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1109\/TMI.2013.2258030","article-title":"Fully automatic segmentation of the proximal femur using Random Forest Regression Voting","volume":"32","author":"Lindner C, Thiagarajah S, Wilkinson JM; arcOGEN Consortium; Wallis GA, Cootes TF.","year":"2013","journal-title":"IEEE Trans Med Imaging"},{"key":"2025070205021885900_keaf141-B17","author":"CIE (Commission Internationale de l'Eclairage)","year":"2004"},{"key":"2025070205021885900_keaf141-B18","first-page":"99","article-title":"On a measure of divergence between two statistical populations defined by their probability distributions","volume":"35","author":"Bhattacharyya","year":"1943","journal-title":"Bull Cal Math Soc"},{"key":"2025070205021885900_keaf141-B19","first-page":"401","article-title":"On a measure of divergence between two multinomial populations","volume":"7","author":"Bhattacharyya","year":"1946","journal-title":"Sankhy\u0101 Indian J Stat"},{"key":"2025070205021885900_keaf141-B20","first-page":"485","article-title":"Raynaud's phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"2025070205021885900_keaf141-B21","doi-asserted-by":"crossref","first-page":"152208","DOI":"10.1016\/j.semarthrit.2023.152208","article-title":"Domain reporting in systemic sclerosis-related Raynaud\u2019s phenomenon: an OMERACT scoping review","volume":"61","author":"Maltez","year":"2023","journal-title":"Sem Arthritis Rheum"},{"key":"2025070205021885900_keaf141-B22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/acr.25038","article-title":"Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon questionnaire: item bank and Short-Form development","volume":"75","author":"Yu","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2025070205021885900_keaf141-B23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/rheumatology\/kead371","article-title":"Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire","volume":"63","author":"Pauling","year":"2024","journal-title":"Rheumatology"},{"key":"2025070205021885900_keaf141-B24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multinational qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025070205021885900_keaf141-B25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.40457","article-title":"A multicentre study of the validity and reliability of responses to hand cold challenge as measured by laser speckle contrast imaging and thermography: outcome measures for systemic sclerosis-related Raynaud's phenomenon","volume":"70","author":"Wilkinson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025070205021885900_keaf141-B26","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.5152\/eurjrheum.2020.19124","article-title":"New perspectives in the imaging of Raynaud's phenomenon","volume":"7","author":"Herrick","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"2025070205021885900_keaf141-B27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.semarthrit.2020.06.018","article-title":"Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: a systematic literature review","volume":"50","author":"Pauling","year":"2020","journal-title":"Sem Arthritis Rheum"},{"key":"2025070205021885900_keaf141-B28","doi-asserted-by":"crossref","first-page":"rkac105","DOI":"10.1093\/rap\/rkac105","article-title":"Feasibility study of mobile phone photography as a possible outcome measure of systemic sclerosis-related digital lesions","volume":"6","author":"Davison","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"2025070205021885900_keaf141-B29","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/rheumatology\/keae371","article-title":"Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: scleroderma App for Lesion VErification)","volume":"63","author":"Davison","year":"2024","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf141\/62387385\/keaf141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4236\/62387385\/keaf141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/7\/4236\/62387385\/keaf141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:02:26Z","timestamp":1751446946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/7\/4236\/8071877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf141","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,12]]}}}